Skip to main content
. 2021 Jun 2;71(708):e538–e546. doi: 10.3399/BJGP.2020.0797

How this fits in

Patients with knee osteoarthritis (OA) frequently require analgesics, but the analgesics commonly used are not ideal as they are either insufficiently effective or have serious side-effects. The authors hypothesised that tricyclic antidepressants (TCAs), which are used as analgesics for other chronically painful conditions, may be helpful for patients with OA. In this randomised, double-blind, placebo-controlled trial, it was found that one TCA, nortriptyline, did not significantly reduce pain or improve physical function, stiffness, or participants’ global assessment of the impact of their OA; as such, nortriptyline is unlikely to be a useful treatment for patients with knee OA.